physostigmine has been researched along with Ophthalmoplegia, Progressive Supranuclear in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 7 (87.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Litvan, I | 1 |
| Atack, JR; Blesa, R; Chase, TN; Clark, K; Grafman, J; Litvan, I; Mouradian, MM; Nichelli, P | 1 |
| Agid, Y; Ben Ayed, S; Blin, J; Malapani, C; Mazetti, P; Mazoyer, B; Pillon, B; Rivaud, S | 1 |
| Chi-Fishman, G; Frattali, CM; Litvan, I; Sonies, BC | 1 |
| Atack, JR; Chase, TN; Litvan, I; May, C; Rapoport, SI; Thal, LJ | 1 |
| Kertzman, C; Litvan, I; Robinson, DL | 1 |
| Chase, TN; Gomez, C; Grafman, J; Litvan, I | 1 |
| Atack, JR; Chase, TN; Gillespie, M; Gomez, C; Kask, AM; Litvan, I; Mouradian, MM | 1 |
1 review(s) available for physostigmine and Ophthalmoplegia, Progressive Supranuclear
| Article | Year |
|---|---|
Cholinergic approaches to the treatment of progressive supranuclear palsy.
Topics: Cholinergic Agonists; Humans; Physostigmine; Succinimides; Supranuclear Palsy, Progressive | 1994 |
7 trial(s) available for physostigmine and Ophthalmoplegia, Progressive Supranuclear
| Article | Year |
|---|---|
Pharmacological evaluation of the cholinergic system in progressive supranuclear palsy.
Topics: Aged; Cognition; Contraindications; Dose-Response Relationship, Drug; Double-Blind Method; Female; Gait; Humans; Infusions, Intravenous; Injections, Intravenous; Male; Memory; Middle Aged; Parasympathetic Nervous System; Parasympatholytics; Physostigmine; Placebos; Psychiatric Status Rating Scales; Psychological Tests; Scopolamine; Supranuclear Palsy, Progressive | 1994 |
Does the enhancement of cholinergic neurotransmission influence brain glucose kinetics and clinical symptomatology in progressive supranuclear palsy?
Topics: Aged; Brain; Dose-Response Relationship, Drug; Double-Blind Method; Eye Movements; Glucose; Humans; Kinetics; Movement; Neuropsychological Tests; Parasympathetic Nervous System; Physostigmine; Supranuclear Palsy, Progressive; Synaptic Transmission | 1995 |
Effects of physostigmine on swallowing and oral motor functions in patients with progressive supranuclear palsy: A pilot study.
Topics: Cholinesterase Inhibitors; Cross-Over Studies; Deglutition; Deglutition Disorders; Double-Blind Method; Female; Humans; Male; Middle Aged; Oropharynx; Physostigmine; Pilot Projects; Supranuclear Palsy, Progressive | 1999 |
Cerebrospinal fluid acetylcholinesterase in progressive supranuclear palsy: reduced activity relative to normal subjects and lack of inhibition by oral physostigmine.
Topics: Acetylcholinesterase; Administration, Oral; Butyrylcholinesterase; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Neurologic Examination; Physostigmine; Receptors, Cholinergic; Supranuclear Palsy, Progressive | 1991 |
Effects of physostigmine on spatial attention in patients with progressive supranuclear palsy.
Topics: Aged; Attention; Cognition; Double-Blind Method; Humans; Middle Aged; Neuropsychological Tests; Physostigmine; Placebos; Space Perception; Supranuclear Palsy, Progressive; Visual Perception | 1990 |
Frontal lobe function in progressive supranuclear palsy.
Topics: Affect; Art; Attention; Cognition; Concept Formation; Frontal Lobe; Humans; Middle Aged; Movement; Physostigmine; Speech; Supranuclear Palsy, Progressive; Thinking; Time Perception | 1990 |
Physostigmine treatment of progressive supranuclear palsy.
Topics: Aged; Double-Blind Method; Female; Humans; Male; Memory Disorders; Middle Aged; Physostigmine; Supranuclear Palsy, Progressive | 1989 |